Excellent Real-World Outcomes of Adults With Burkitt Lymphoma Treated With CODOX-M/IVAC Plus or Minus Rituximab
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15262
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 9, 2018
Authors
Publisher
Wiley